Over the past two decades, the popularity of dietary supplements (i.e., vitamins, minerals, herbs, amino acids, and other substances) has continued to soar. But, during the same time, manufacturers of dietary supplements have been subject to an increasing number of laws and regulations—including the Dietary Supplement Health and Education Act of 1994, the Public Health Security and Bioterrorism Preparedness and Response Act of 2002, the Dietary Supplement and Nonprescription Drug Consumer Protection Act of 2006, the Lanham Act, state laws regarding false advertising and deceptive trade practices, and the Federal Trade Commission Act, to name a few—and successfully navigating their requirements can be a huge challenge.

Epstein Becker Green guides dietary supplement companies through the maze of relevant laws and requirements, as well as through U.S. Food and Drug Administration (FDA) regulatory issues and litigation with the Federal Trade Commission (FTC). We are problem solvers with experience addressing all kinds of situations throughout the lifecycle of dietary supplements—from the earliest stages of a product and brand development through the approval or clearance process and into the product’s post-market life. And the depth and breadth of our experience allows us to tailor our approaches to meet our clients’ legal, regulatory, and business goals.